Results 11 to 20 of about 100,425 (314)

Mesothelioma in the Calf [PDF]

Pathologia veterinaria, 1967
Three cases of mesothelioma in calves are described. Two were full-term foetuses, the other was 3 months old. There was ascites in all three. The tumours formed multiple, discrete nodules on the parietal and visceral peritoneum, and in the older calf also on the pleura. Lymph nodes were unaffected.
A. Baskerville
openaire   +4 more sources

Integrative eQTL and Mendelian randomization analysis reveals key genetic markers in mesothelioma. [PDF]

Respir Res
Background Mesothelioma is a rare cancer that originates from the pleura and peritoneum, with its incidence increasing due to asbestos exposure. Patients are frequently diagnosed at advanced stages, resulting in poor survival rates.
Li J, Wang X, Lin Y, Li Z, Xiong W.
europepmc   +2 more sources

Malignant pleural mesothelioma patients’ experience by gender: findings from a cross-sectional UK-national questionnaire

BMJ Open Respiratory Research, 2022
Objectives Malignant mesothelioma is an aggressive malignancy of mesothelial surfaces, most commonly those of the pleura. The aim of this study was to understand, using a national questionnaire, the gendered care experiences of patients with malignant ...
Liz Darlison, Lorraine Creech, Angela Tod, Michaela Senek, Steve Robertson   +4 more
doaj   +1 more source

Predicting Cancer Using Supervised Machine Learning: Mesothelioma [PDF]

Technology and Health Care, 29(1), 45-58 (2021), 2021
Background: Pleural Mesothelioma (PM) is an unusual, belligerent tumor that rapidly develops into cancer in the pleura of the lungs. Pleural Mesothelioma is a common type of Mesothelioma that accounts for about 75% of all Mesothelioma diagnosed yearly in the U.S. Diagnosis of Mesothelioma takes several months and is expensive.
arxiv   +1 more source

Cytoplasmic HuR Expression Enhances Chemoresistance in Pleural Mesothelioma Through Increased Expression of CALB2, Promotion of the E2F Pathway, and Suppression of the p53 Pathway. [PDF]

Thorac Cancer
Introduction Chemotherapy is crucial for treating pleural mesothelioma; however, the outcomes are poor, necessitating an urgent need to study the mechanism of chemotherapy resistance in mesothelioma cells.
Kirimura S, Kurata M, Ishibashi H, Taniguchi Y, Kinowaki Y, Sugita K, Okubo K.   +6 more
europepmc   +2 more sources

The therapeutic implications of the genomic analysis of malignant pleural mesothelioma

Nature Communications, 2021
Delineation of the genomic complexities of malignant pleural mesothelioma (MPM) has lagged behind other malignancies. Zhang et al. meaningfully add to our understanding of MPM, and their findings emphasize the need to combine drug development efforts ...
Marjorie G. Zauderer
doaj   +1 more source

Must countries shoulder the burden of mesothelioma to ban asbestos? A global assessment

BMJ Global Health, 2022
Introduction Mesothelioma is a key asbestos-related disease (ARD) but can be difficult to diagnose. Countries presumably ban asbestos to reduce future ARD burdens, but it is unknown if countries ban asbestos as a consequence of ARD burdens.
Seong-Kyu Kang, Ro-ting Lin, Sonja Klebe, Ken Takahashi, Odgerel Chimed-Ochir, Anna K Nowak, Tatsuhiko Kubo, Sugio Furuya, Emma M Rath, Yui Yumiya, Kim Brislane   +10 more
doaj   +1 more source

Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033. [PDF]

PLoS ONE, 2017
Malignant mesothelioma is a malignant tumor on the pleura or the peritoneum caused mostly by asbestos. Although asbestos is not currently used in South Korea, the incidence of mesothelioma is increasing due to its long latent period. This study predicted
Kyeong Min Kwak, Domyung Paek, Seung-Sik Hwang, Young-Su Ju   +3 more
doaj   +1 more source

Asbestos Consumption and Malignant Mesothelioma Mortality Trends in the Major User Countries

Annals of Global Health, 2023
Background: The causal association between mesothelioma and asbestos exposure is conclusive, and many studies have proved that the trend in asbestos use is a strong predictor of the pattern in mesothelioma cases with an adequate latency time (generally ...
Claudio Gariazzo, Antonio Gasparrini, Alessandro Marinaccio   +2 more
doaj   +1 more source

Understanding clinical decision-making in mesothelioma care: a mixed methods study

BMJ Open Respiratory Research, 2022
Introduction Malignant pleural mesothelioma is a rare, incurable cancer arising from previous asbestos exposure; patients have a poor prognosis, with a median survival rate of 8–14 months. Variation in mesothelioma clinical decision-making remains common
Najib Rahman, Catherine Henshall, Edward McKeown, Zoe Davey, Helen Walthall, Hannah Ball, Mitra Shahidi, John Park, Paul Dawson, Anand Sundralingam   +9 more
doaj   +1 more source